AC
BMY icon

ASB Consultores’s Bristol-Myers Squibb BMY Stock Holding History

ASB Consultores’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-4,110
Closed -$232K – 138
2024
Q4 		$232K Buy
+4,110
New +$230K 0.1% 183
2024
Q2 		– Sell
-8,200
Closed -$445K – 208
2024
Q1 		$445K Buy
+8,200
New +$418K 0.11% 130
2023
Q4 		– Sell
-7,361
Closed -$427K – 120
2023
Q3 		$427K Sell
7,361
-3,235
-31% -$198K 0.17% 57
2023
Q2 		$678K Buy
10,596
+310
+3% +$20.8K 0.33% 60
2023
Q1 		$713K Buy
10,286
+1,561
+18% +$110K 0.29% 45
2022
Q4 		$628K Buy
8,725
+519
+6% +$39.1K 0.26% 46
2022
Q3 		$583K Buy
8,206
+588
+8% +$42.7K 0.27% 44
2022
Q2 		$587K Buy
7,618
+116
+2% +$8.84K 0.26% 42
2022
Q1 		$548K Sell
7,502
-548
-7% -$36.8K 0.23% 72
2021
Q4 		$502K Buy
+8,050
New +$472K 0.25% 80

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

ASB Consultores's BMY Position: Q1 2025 in Review

ASB Consultores sold out of Bristol-Myers Squibb (BMY) in Q1 2025, closing a stake of 4,110 shares — an estimated $232K sold.

ASB Consultores first reported a position in BMY in Q4 2021 and held it in 10 quarters. The position peaked at $713K in Q1 2023. 2,485 funds tracked by Wall St. Rank hold BMY as of Q1 2025.

  • ASB Consultores reported no remaining Bristol-Myers Squibb position as of Q1 2025 after selling out during the quarter.
  • ASB Consultores sold 4,110 Bristol-Myers Squibb shares in Q1 2025, an estimated $232K.
  • ASB Consultores first reported a position in Bristol-Myers Squibb in Q4 2021 and held it in 10 quarters.
  • ASB Consultores's Bristol-Myers Squibb position peaked at $713K in Q1 2023.
  • 2,485 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2025.

Based on ASB Consultores's 13F filing for Q1 2025, filed 13 May 2025.